Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review — Isabella Pacchiarotti (2019) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review
Shared by
Eduard Vieta
Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review
Article
2019
en
Authors
+6 more
IP
Isabella Pacchiarotti
JT
Jari Tiihonen
GK
Georgios D. Kotzalidis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2010
[Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder].
Antoni Benabarre
,
P Castro
,
José Sánchez‐Moreno
,
Anabel Martínez‐Arán
,
Manel Salamero
,
Andréa Murru
,
Carolina Franco
,
Eduard Vieta
Article
2008
P.3.c.008 Open-label over effectiveness of long-acting risperidone as maintenance therapy of bipolar and schizoaffective disorders
P. Castro-Loli
,
Antonio Benabarre
,
Anabel Martínez‐Arán
,
José Sánchez‐Moreno
,
Manel Salamero
,
Andréa Murru
,
Eduard Vieta
Article
2024
Early use of long‐acting injectable antipsychotics in bipolar disorder type I: An expert consensus
Eduard Vieta
,
Mauricio Tohen
,
Diane McIntosh
,
Lars Vedel Kessing
,
Martha Sajatovic
,
Roger S. McIntyre
Article
2017
The Role of Long Acting Antipsychotics in Bipolar Disorder
Eduard Vieta
Article
2007
Oxcarbazepine in the treatment of bipolar and schizoaffective disorders
Ekaterine Popova
,
Caroline Leighton
,
Antoni Bernabarre
,
Miquel Bernardo
,
Eduard Vieta
Discussion(0)
No comments yet. Be the first to comment.